01 Jan, 1970
Understand the pembrolizumab mechanism of action in plain English. Learn how Keytruda blocks PD-1 receptors, reactivates T-cells to fight cancer, its approved uses, common side effects, timeline, and patient considerations. Explains immune checkpoint inhibition clearly.